InnoCare Pharma Limited (SHA:688428)
China
· Delayed Price · Currency is CNY 24.99
+0.15 (0.60%)
At close: Dec 5, 2025
InnoCare Pharma Revenue
InnoCare Pharma had revenue of 383.89M CNY in the quarter ending September 30, 2025, with 38.09% growth. This brings the company's revenue in the last twelve months to 1.43B, up 58.75% year-over-year. In the year 2024, InnoCare Pharma had annual revenue of 1.01B with 36.68% growth.
Revenue (ttm)
1.43B
Revenue Growth
+58.75%
P/S Ratio
17.75
Revenue / Employee
1.21M
Employees
1,089
Market Cap
25.32B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |